公开(公告)号：US20190192143A1

公开(公告)日：2019-06-27

申请号：US16288356

申请日：2019-02-28

申请人： Ethicon LLC

发明人： Frederick E. Shelton, IV ,  Jason L. Harris ,  Michael J. Vendely ,  Charles J. Scheib

IPC分类号： A61B17/072 ,  A61L31/16 ,  A61B17/00 ,  A61B17/10

CPC分类号： A61B17/072 ,  A61B17/00 ,  A61B17/07207 ,  A61B17/07292 ,  A61B17/105 ,  A61B17/1155 ,  A61B2017/00004 ,  A61B2017/00809 ,  A61B2017/00884 ,  A61B2017/00893 ,  A61B2017/00898 ,  A61L31/16 ,  A61L2300/414 ,  A61L2430/22

摘要： Tissue adhesions using surgical adjuncts and medicants are provided. In general, an implantable adjunct can have one or more medicants releasably retained therein that are configured to induce tissue adhesions. The adjunct can be configured to be applied to lung tissue in conjunction with surgical staples using a surgical stapler. Pleurodesis can be encouraged through delivery of the adjunct to the lung tissue.

公开(公告)号：US20180242993A1

公开(公告)日：2018-08-30

申请号：US15585679

申请日：2017-05-03

申请人： Edward KNOWLTON

发明人： Edward KNOWLTON

IPC分类号： A61B17/322 ,  A61B17/3205 ,  A61B17/34 ,  A61B90/00 ,  A61F2/10 ,  A61M19/00 ,  A61B17/54 ,  A61B17/3209 ,  A61B17/3211 ,  A61M5/178 ,  A61F13/00 ,  A61F2/04 ,  A61L27/36 ,  A61L27/20 ,  A61L27/52 ,  A61L27/02 ,  A61L27/54

CPC分类号： A61B17/322 ,  A61B10/0233 ,  A61B17/32 ,  A61B17/320068 ,  A61B17/32053 ,  A61B17/32093 ,  A61B17/3211 ,  A61B17/3468 ,  A61B17/54 ,  A61B90/02 ,  A61B2017/00752 ,  A61B2017/00761 ,  A61B2017/00792 ,  A61B2017/00884 ,  A61B2017/00951 ,  A61B2017/00969 ,  A61B2017/306 ,  A61B2017/320052 ,  A61B2017/320064 ,  A61B2017/32007 ,  A61B2017/3225 ,  A61B2018/00994 ,  A61B2217/005 ,  A61F2/042 ,  A61F2/105 ,  A61F13/00 ,  A61F2002/044 ,  A61F2002/047 ,  A61F2013/00157 ,  A61F2013/0028 ,  A61L27/025 ,  A61L27/20 ,  A61L27/362 ,  A61L27/3691 ,  A61L27/48 ,  A61L27/52 ,  A61L27/54 ,  A61L2300/414 ,  A61L2400/06 ,  A61M5/178 ,  A61M19/00 ,  A61M2037/0023 ,  C08L5/08

摘要： Systems, instruments, methods, and compositions are described involving removing a portion of the epidermis within a donor site on a subject, and harvesting dermal plugs within the donor site. An injectable filler is formed by mincing the dermal plugs. The injectable filler is configured for injecting into a recipient site on the subject.

公开(公告)号：US20180214141A1

公开(公告)日：2018-08-02

申请号：US15852846

申请日：2017-12-22

申请人： TransCaval Solutions, Inc.

发明人： Max Pierre Mendez

IPC分类号： A61B17/00

CPC分类号： A61B17/0057 ,  A61B2017/00477 ,  A61B2017/00526 ,  A61B2017/00575 ,  A61B2017/00584 ,  A61B2017/00592 ,  A61B2017/00597 ,  A61B2017/0061 ,  A61B2017/00623 ,  A61B2017/00867 ,  A61B2017/00884 ,  A61F2/07

摘要： An implant includes a collapsible tubular body, which, in an expanded configuration, extends from a first end to a second end centered along a longitudinal axis. The implant includes a hub coupled to the tubular body between the first and second ends. The hub is configured to removably connect to a deployment device. The deployment device is configured to manipulate and position the implant towards an implantation site in a vessel of a patient.

公开(公告)号：US20180193010A1

公开(公告)日：2018-07-12

申请号：US15399968

申请日：2017-01-06

申请人： Ethicon, Inc.

发明人： Jerome B. Riebman ,  Leo B. Kriksunov

IPC分类号： A61B17/00 ,  B29C65/48 ,  B29C65/02

CPC分类号： B29C65/02 ,  A61B17/0057 ,  A61B17/07292 ,  A61B2017/00004 ,  A61B2017/00526 ,  A61B2017/00659 ,  A61B2017/00884 ,  A61B2017/00893 ,  A61F13/00008 ,  A61F2013/00463 ,  A61L15/28 ,  A61L15/32 ,  A61L15/42 ,  A61L15/425 ,  A61L15/64 ,  A61L24/001 ,  A61L24/0036 ,  A61L24/0042 ,  A61L24/08 ,  A61L24/104 ,  A61L24/106 ,  A61L24/108 ,  A61L2400/04 ,  B29C65/48 ,  B29L2031/753 ,  C08L1/04

摘要： The present invention relates generally to agents and devices for promoting hemostasis and, more particularly, to bioresorbable hemostatic pads or patches releasably supported on non-resorbable scaffolds for ease of delivery in the field. A sealant and/or hemostat delivery device comprises a resorbable hemostatic pad having a wound facing side and an opposite back side, with a hemostatic and/or wound sealing agent disposed on the wound facing side; a non-resorbable scaffold having an attachment zone on said scaffold; wherein said hemostatic pad is releasably attached with the back side to the attachment zone. The bond between the scaffold and the resorbable hemostatic pad or wound dressing is either (i) severed prior to removal of the scaffold or (ii) is weakened due to the adhesive bonding them together being moisture-deactivated, or (iii) is released by mechanical disentanglement.

公开(公告)号：US09919086B2

公开(公告)日：2018-03-20

申请号：US15241590

申请日：2016-08-19

申请人： Abiomed, Inc.

发明人： Robert Dowling ,  Robert T. V. Kung ,  Paul Spence ,  Thorsten Siess ,  Gerd Spanier ,  Eric Gratz ,  Caitlyn Hastie

IPC分类号： A61N1/362 ,  A61M1/10 ,  A61M1/12 ,  A61F2/06 ,  A61B17/11 ,  A61M1/36 ,  A61F2/00 ,  A61M25/00 ,  A61B17/00

CPC分类号： A61M1/1008 ,  A61B17/11 ,  A61B2017/00884 ,  A61B2017/1135 ,  A61F2/0077 ,  A61F2/064 ,  A61F2250/0026 ,  A61M1/101 ,  A61M1/1032 ,  A61M1/106 ,  A61M1/107 ,  A61M1/12 ,  A61M1/122 ,  A61M1/3653 ,  A61M1/3655 ,  A61M25/0043 ,  A61M25/0071 ,  A61M25/0074 ,  A61M2025/006 ,  A61M2206/10

摘要： A blood flow conduit includes a first conduit portion defining a first portion of a lumen; and a second conduit portion defining a second portion of a lumen. At least one of the first or second conduit portions may include a tip portion and the other of the first or second conduit portions may include an enlarged area.

公开(公告)号：US09901352B2

公开(公告)日：2018-02-27

申请号：US14964930

申请日：2015-12-10

申请人： AtriCure, Inc.

发明人： Frank M. Fago ,  Kimberly Gray

IPC分类号： A61B17/08 ,  A61B17/122 ,  A61B17/12 ,  A61B17/00

CPC分类号： A61B17/1227 ,  A61B17/08 ,  A61B17/083 ,  A61B17/12 ,  A61B17/122 ,  A61B2017/00526 ,  A61B2017/00884

摘要： An occlusion clip comprising: (a) a first elongated occlusion arm; (b) a second elongated occlusion arm; (c) a first elongated biasing arm coupled to a distal portion of the first elongated occlusion arm; (d) a second elongated biasing arm coupled to a distal portion of the second elongated occlusion arm, where a proximal portion of the first elongated biasing arm is coupled to a proximal portion of the second elongated biasing arm, where the first elongated occlusion arm extends parallel to the first elongated bias arm along a majority of its length, and where the second elongated occlusion arm extends parallel to the second elongated bias arm along a majority of its length.

公开(公告)号：US20180008744A1

公开(公告)日：2018-01-11

申请号：US15269802

申请日：2016-09-19

申请人： BIOACTIVE SURGICAL, INC.

发明人： Richard H. Spedden ,  Laura J. Pingel ,  Lew C. Schon

IPC分类号： A61L17/00 ,  A61L17/06 ,  A61B17/06 ,  D06B1/10 ,  A61B17/00

CPC分类号： A61L17/005 ,  A61B17/06114 ,  A61B17/06166 ,  A61B2017/00884 ,  A61B2017/00893 ,  A61B2017/06185 ,  A61L17/06 ,  A61L2300/404 ,  A61L2300/414 ,  A61L2300/42 ,  A61L2300/45 ,  A61L2300/604 ,  A61L2300/64 ,  D06B1/10

摘要： Materials and methods for immobilizing bioactive molecules, stem and other precursor cells, and other agents of therapeutic value in surgical sutures and other tissue scaffold devices are described herein. Broadly drawn to the integration and incorporation of bioactive materials into suture constructs, tissue scaffolds and medical devices, the present invention has particular utility in the development of novel systems that enable medical personnel performing surgical and other medical procedures to utilize and subsequently reintroduce bioactive materials extracted from a patient (or their allogenic equivalents) to a wound or target surgical site.

公开(公告)号：US09861726B2

公开(公告)日：2018-01-09

申请号：US14853652

申请日：2015-09-14

申请人： COVIDIEN LP

发明人： Joe D. Sartor ,  Anthony B. Ross ,  Stephen Wohlert

IPC分类号： A61F2/04 ,  A61L27/54 ,  A61B17/11 ,  A61L27/24 ,  A61L27/56 ,  A61M25/00 ,  A61F2/958 ,  A61L27/36 ,  A61L27/38 ,  A61B17/00

CPC分类号： A61L27/54 ,  A61B17/11 ,  A61B2017/00274 ,  A61B2017/00292 ,  A61B2017/00884 ,  A61B2017/1135 ,  A61F2/04 ,  A61F2/958 ,  A61F2002/047 ,  A61F2002/9583 ,  A61L27/24 ,  A61L27/3683 ,  A61L27/3834 ,  A61L27/56 ,  A61L2300/414 ,  A61L2430/22 ,  A61M25/0017

摘要： A method for coupling a body conduit to tissue is provided. The method includes engaging an implant about an outer surface of a catheter. The implant receives a bioactive agent having tissue growth properties. The method involves inserting the catheter through the body conduit and into a tissue opening across a resected area, positioning the implant in the resected area, inflating a balloon to anchor the catheter within the tissue opening such that the implant bridges the body conduit and the tissue opening across the resected area, and maintaining the catheter and the implant in vivo to enable the bioactive agent to secure the implant in the resected area to permanently bridge the body conduit and the tissue opening.

公开(公告)号：US09839420B2

公开(公告)日：2017-12-12

申请号：US13433136

申请日：2012-03-28

申请人： Frederick E. Shelton, IV ,  Katherine J. Schmid ,  Charles J. Scheib ,  Taylor W. Aronhalt ,  Matthew M. Lang ,  Steven G. Hall ,  Chester O. Baxter, III

发明人： Frederick E. Shelton, IV ,  Katherine J. Schmid ,  Charles J. Scheib ,  Taylor W. Aronhalt ,  Matthew M. Lang ,  Steven G. Hall ,  Chester O. Baxter, III

IPC分类号： A61B17/04 ,  A61B17/10 ,  A61B17/068 ,  A61B17/072 ,  A61L17/00 ,  A61B17/064 ,  A61B17/115 ,  A61B17/00 ,  A61B17/29 ,  A61B17/32 ,  A61B90/00

CPC分类号： A61B17/068 ,  A61B17/00491 ,  A61B17/0643 ,  A61B17/0644 ,  A61B17/072 ,  A61B17/07207 ,  A61B17/07292 ,  A61B17/1155 ,  A61B17/2909 ,  A61B2017/00004 ,  A61B2017/00477 ,  A61B2017/00526 ,  A61B2017/0053 ,  A61B2017/00561 ,  A61B2017/00818 ,  A61B2017/00862 ,  A61B2017/00884 ,  A61B2017/00889 ,  A61B2017/00893 ,  A61B2017/00898 ,  A61B2017/00942 ,  A61B2017/00951 ,  A61B2017/07228 ,  A61B2017/07235 ,  A61B2017/07242 ,  A61B2017/07264 ,  A61B2017/07271 ,  A61B2017/07278 ,  A61B2017/07285 ,  A61B2017/2908 ,  A61B2017/2919 ,  A61B2017/2923 ,  A61B2017/2927 ,  A61B2017/2933 ,  A61B2017/2936 ,  A61B2017/2946 ,  A61B2017/320052 ,  A61B2090/0811 ,  A61L17/005 ,  A61L2300/102 ,  A61L2300/232 ,  A61L2300/45 ,  F04C2270/0421 ,  Y10T29/49826

摘要： A stapling assembly comprising a tissue thickness compensator is disclosed. The tissue thickness compensator comprises a body portion comprising a porous material and a plurality of cavities defined in the body portion, wherein the cavities are aligned with forming surfaces of an anvil such that fasteners of a fastener cartridge are configured to at least one of the cavities when the fasteners are ejected from the fastener cartridge or capture the cavities and compress the cavities within the tissue thickness compensator when the fasteners are ejected from the fastener cartridge and formed by forming surfaces of the anvil. The stapling assembly further comprises at least one medicament positioned within each cavity prior to firing the stapler, wherein the medicament is different than the porous material.

公开(公告)号：US20170056567A1

公开(公告)日：2017-03-02

申请号：US14840527

申请日：2015-08-31

申请人： Ethicon Endo-Surgery, LLC

发明人： Jason L. Harris ,  Michael J. Vendely ,  Chad E. Eckert ,  Frederick E. Shelton, IV

IPC分类号： A61L31/16 ,  A61L31/14 ,  A61B17/072

CPC分类号： A61L31/16 ,  A61B17/00491 ,  A61B17/064 ,  A61B17/0644 ,  A61B17/07207 ,  A61B17/07292 ,  A61B17/1155 ,  A61B2017/00004 ,  A61B2017/00884 ,  A61B2017/00893 ,  A61B2017/00898 ,  A61B2017/00964 ,  A61B2017/07271 ,  A61B2017/07285 ,  A61L31/145 ,  A61L2400/06 ,  A61L2430/34

摘要： Various exemplary composite adjunct materials for delivering medicants are provided. In general, the adjunct material can be configured to be delivered to tissue by deployment of staples from a cartridge body of a surgical stapler. The adjunct material includes a conformable region and a distinct reinforcing region that form the composite structure. An effective amount of at least one medicant can be disposed within and releasable from at least one of the conformable region and the reinforcing region and can provide a desired effect on tissue in-growth in a predetermined manner.

摘要翻译： 提供了用于递送药剂的各种示例性复合辅助材料。 通常，辅助材料可以构造成通过从外科缝合器的药筒主体部署缝钉而被递送到组织。 辅助材料包括形成复合结构的适形区域和不同的增强区域。 至少一种药剂的有效量可以设置在适形区域和增强区域中的至少一个中并且可从其释放，并且可以以预定方式提供对组织生长的期望效果。